A sensitive reversed phase HPLC method for the determination of curcumin

Pharmacognosy Magazine

Volumn 4, Issue 17, 2009, Pages 71-74

  Ramshankar, Yadav Vivek ^a   Suresh, Sarasija ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Curcumin; HPLC; Limit of detection; Natural drug

Indexed keywords

ACETIC ACID; ACETONITRILE; CURCUMIN; TETRAHYDROFURAN;

ACCURACY; ARTICLE; DEVICE; DRUG DETERMINATION; FLOW RATE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ASSAY;

EID: 74049151161     PISSN: 09731296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. K.C. Das, C.K. Das, Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem. Biophys. Res. Commun. 295: 62 (2002).
2. A.J. Ruby, G. Kuttan, K.D. Babu, K.N. Rajasekharan, R. Kuttan, Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 94: 79 (1995).
3. Literat, F. Su, M. Norwicki, M. Durand, R. Ramanathan, C.A. Jones, P. Minoo, K.Y. Kwong, Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci. 70: 253 (2001).
4. W. Lukita-Atmadja, Y. Ito, G.L. Baker, R.S. McCuskey, Effect of Curcuminoids as Anti-Inflammatory Agents on the Hepatic Microvascular Response to Endotoxin. Shock 17: 399 (2002).
5. J.A. Bush, K.-J.J. Cheung, G. Li, Curcumin induces apoptosis in human melanoma cells through a fasreceptor/caspase-8 pathway independent of p53 Exp. Cell Res. 271: 305 (2001).
6. A.J. Gescher, R.A. Sharma, W.P. Steward, Cancer chemoprevention by dietary constituents: A salutary tale of failure and promise Lancet. Oncol. 2 (2001) 371.
7. Z.-M. Shao, Z.-Z. Shen, C.-H. Liu, M.R. Sartippour, V.L. Go, D. Heber, M. Nguyen, Sensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasma. Int. J. Cancer. 98: 234 (2002).
8. C. Ireson, S. Orr, D.J.L. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, W.P. Steward, A. Gescher, Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production. Cancer Res. 61: 1058 (2001).
9. C.A. Shih, J.K. Lin, of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis. 14: 709 (1994).
10. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, G.M. Cole, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21: 8370 (2001).
11. M.-H. Pan, T.-M. Huang, J.-K. Lin, Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues. Drug Metab. Dispos. 27: 486 (1999).
12. S. Oetari, M. Sudibyo, J.N.M. Commandeur, R. Samhoedi, N.P.E. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Vermeulen, Biochem. Pharmacol. 51: 39 (1996).
13. X.-G. He, L.-Z. Lin, L.-Z. Lian, M. Lindenmaier. Sesquiterpenoids in turmeric (Curcuma longa). J. Chromatogr. A. 818: 127 (1998).
14. R. Hiserodt, T.G. Hartman, C.-T. Ho, R.T. Rosen, Characterization of powered turmeric by liquid chromatography-mass spectrometry and gas chromatographymass spectrometry. J. Chromatogr. A. 740: 51 (1996).
15. V. Ravindranath, N. Chandrasekhara, Absorption and tissue distribution of curcumin in rats. Toxicology. 22: 337 (1982).
16. A.Asai, T. Miyazawa, Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 67: 2785 (2000).
17. D.D. Heath, M.A. Pruitt, D.E. Brenner, C.L. Rock, Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J. Chromatogr. B. 783: 287 (2003)